, target levels < 1.4 mmol/L (55
mg/dL) are recommended.
Best Practice Statement

24. In a person with diabetes and symptomatic peripheral artery disease:
treatment with single antiplatelet therapy should be used,
treatment with clopidogrel should be considered as ï¬rst choice in
preference to aspirin,
combination therapy with aspirin (75 mg to 100 mg once daily) plus
low dose rivar